Join the 200th Anniversary Celebration

Original Article

Cellular-Telephone Use and Brain Tumors

Peter D. Inskip, Sc.D., Robert E. Tarone, Ph.D., Elizabeth E. Hatch, Ph.D., Timothy C. Wilcosky, Ph.D., William R. Shapiro, M.D., Robert G. Selker, M.D., Howard A. Fine, M.D., Peter M. Black, M.D., Jay S. Loeffler, M.D., and Martha S. Linet, M.D.

N Engl J Med 2001; 344:79-86January 11, 2001

Abstract

Background

Concern has arisen that the use of hand-held cellular telephones might cause brain tumors. If such a risk does exist, the matter would be of considerable public health importance, given the rapid increase worldwide in the use of these devices.

Methods

We examined the use of cellular telephones in a case–control study of intracranial tumors of the nervous system conducted between 1994 and 1998. We enrolled 782 patients through hospitals in Phoenix, Arizona; Boston; and Pittsburgh; 489 had histologically confirmed glioma, 197 had meningioma, and 96 had acoustic neuroma. The 799 controls were patients admitted to the same hospitals as the patients with brain tumors for a variety of nonmalignant conditions.

Results

As compared with never, or very rarely, having used a cellular telephone, the relative risks associated with a cumulative use of a cellular telephone for more than 100 hours were 0.9 for glioma (95 percent confidence interval, 0.5 to 1.6), 0.7 for meningioma (95 percent confidence interval, 0.3 to 1.7), 1.4 for acoustic neuroma (95 percent confidence interval, 0.6 to 3.5), and 1.0 for all types of tumors combined (95 percent confidence interval, 0.6 to 1.5). There was no evidence that the risks were higher among persons who used cellular telephones for 60 or more minutes per day or regularly for five or more years. Tumors did not occur disproportionately often on the side of head on which the telephone was typically used.

Conclusions

These data do not support the hypothesis that the recent use of hand-held cellular telephones causes brain tumors, but they are not sufficient to evaluate the risks among long-term, heavy users and for potentially long induction periods.

Media in This Article

Figure 1Percentage of Controls Who Had Used a Cellular Telephone More Than Five Times, According to the Year of the Interview and Type of Cellular Telephone (Panel A), Age at the Time of the Interview and Sex (Panel B), Self-Reported Annual Household Income (Panel C), and Level of Education (Panel D).
Table 1Selected Characteristics of Patients with Brain Tumors and Control Patients.
Article

Hand-held cellular telephones were introduced to the U.S. market in 19841 but were not widely used until the mid-1990s. By early 2000, the number of subscribers to cellular-telephone services had grown to an estimated 92 million in the United States and 500 million worldwide.2,3 Some concern has arisen about adverse health effects, especially the possibility that the low-power microwave-frequency signal transmitted by the antennas on handsets might cause brain tumors or accelerate the growth of subclinical tumors.4-8 It is generally agreed that the heating of brain tissue by cellular telephones is negligible, and that any carcinogenic effect would have to be mediated through a nonthermal mechanism, the nature and existence of which remain a matter of speculation.5,7-13 Direct genotoxic effects are unlikely.7,14-16

Data concerning the risk of cancer associated with the exposure of humans to nonionizing radiation of the frequencies used by cellular telephones are limited,4,6,7,17-19 and review panels have called for additional research.5,8,20-22 We report the results of a case–control study that was initiated in 1993, shortly after the possibility of a link between use of cellular telephones and brain tumors received extensive media attention and elicited public concern.

Methods

Study Setting and Population

The study methods have been described in detail previously.23 The study was conducted at hospitals in Boston (Brigham and Women's Hospital); Phoenix, Arizona (St. Joseph's Hospital and Medical Center); and Pittsburgh (Western Pennsylvania Hospital). Each is a regional referral center for the diagnosis and treatment of brain tumors. Institutional review boards at the National Cancer Institute and all participating hospitals approved the protocol, and written informed consent was obtained from each subject or from his or her proxy. Enrollment began in June of 1994 and ended in August of 1998. The study was restricted to adults 18 years old or older who received care at one of the participating hospitals, resided within 50 miles of the hospital (or within Arizona, in the case of the Phoenix center), and could understand English or Spanish.

Eligible patients with tumors were those in whom a first intracranial glioma or neuroepitheliomatous tumor (codes 9380 to 9473 and 9490 to 9506 of the International Classification of Diseases for Oncology, 2nd edition [ICD-O-2]24), hereafter referred to as glioma, intracranial meningioma (ICD-O-2 codes 9530 to 9538), or acoustic neuroma (ICD-O-2 code 9560) had been diagnosed within the eight weeks preceding hospitalization at a participating hospital. Microscopical confirmation was required for gliomas and meningiomas, and a confirmatory magnetic resonance imaging (MRI) or computed tomographic (CT) scan was required for acoustic neuromas (96 percent of which were also confirmed microscopically). The tumor grade of gliomas was classified according to the guidelines of Kleihues et al.25,26 The location of the tumor was determined on the basis of the MRI, CT, and surgical reports. Of the potentially eligible patients with tumors, 92 percent agreed to participate in the study. Most (80 percent) were enrolled and interviewed within three weeks after the qualifying diagnosis.

The controls were patients who were admitted to the same hospitals for a variety of nonmalignant conditions and were frequency-matched to the total group of patients with tumors according to hospital, age (in 10-year strata), sex, race or ethnic group, and proximity of their residence to the hospital (0 to 8 km, >8 to 24 km, >24 to 48 km, >48 to 80 km, or >80 km [0 to 5 mi, >5 to 15 mi, >15 to 30 mi, >30 to 50 mi, or >50 mi]). Priority for approaching candidates for the control group was determined by the relative numbers of patients with tumors and controls in the different strata. Of the eligible controls who were contacted, 799 (86 percent) participated.

Data Collection

A research nurse administered a computer-assisted, personal interview in the hospital. Proxy interviews were conducted if the subject was too ill or functionally impaired or had died. Proxy interviews were necessary for 16 percent of the patients with glioma, 8 percent of the patients with meningioma, 3 percent of the patients with acoustic neuroma, and 3 percent of the controls. The usual proxy was the spouse. Interviews were audiotaped if the respondent consented, and nearly all respondents did so.

The interview questions concerned the use of hand-held cellular telephones (with the antenna on the handset), car telephones, and transportable cellular telephones with separate battery packs.4 Participants were asked about the calendar years of the first and last use; the duration of “regular” use (defined as at least two calls per week within this period); the usual frequency of use (in minutes per day); and the hand usually used to hold the handset. The questions concerning the duration and frequency of use were asked only of persons who reported using a particular type of telephone more than five times in their lives. A card was shown displaying photographs of different types of cellular and cordless telephones, and the interviewer's script included a description of the distinguishing features of each type. The managers of the study listened to audiotapes of this portion of the interview for all study subjects and corrected the data when any discrepancies were found.

Also covered in the interview were the subject's educational level, household income, type of health insurance coverage, religion, marital status, history of medical exposure to ionizing radiation, and handedness. The subjects' addresses were linked with 1990 U.S. Census data files to determine the median household income for the census block or tract in which the person resided at the time of hospital admission.

Statistical Analysis

Conditional logistic regression27,28 was used to estimate odds ratios, compute confidence intervals, and perform likelihood-ratio tests (two-sided tests at an α level of 0.05). Odds ratios were used as estimates of the relative risk. In addition to the matching variables, the analyses accounted for the date of the interview (a continuous variable), the type of respondent (the subject, a proxy, or both), educational level (less than high school, high school or general equivalency diploma, one to three years of college, or four years of college or more), annual household income (six categories, from less than $15,000 to $75,000 or more), type of health coverage, marital status, religion, history of radiotherapy to the head or neck, and handedness.

The association between the laterality of the tumor and the self-reported laterality of telephone use was examined among the patients with tumors. The relative risk associated with the use of hand-held cellular telephones was estimated as (√OR+1) ÷ 2 (where OR denotes odds ratio), on the basis of an approach described in the Appendix and elsewhere (NAPS). Two-sided P values for tests of independence were based on Fisher's exact test.

Results

Characteristics of Patients with Tumors and Controls

The 782 patients with tumors included 489 with glioma, 197 with meningioma, and 96 with acoustic neuroma (Table 1Table 1Selected Characteristics of Patients with Brain Tumors and Control Patients.). Nearly 71 percent of the patients with gliomas had been given a diagnosis of glioblastoma or other type of astrocytoma, and 17 percent a diagnosis of oligodendroglioma or mixed glioma (mostly oligoastrocytomas). Patients with high-grade gliomas outnumbered those with low-grade gliomas (354 vs. 135). The ratios of men to women were 1.3 among patients with glioma, 0.3 among patients with meningioma, and 0.6 among those with acoustic neuroma. The most common reasons for hospitalization among the 799 controls were injuries (197) and disorders of the circulatory (179), musculoskeletal (172), digestive (92), and nervous (58) systems. Diagnoses in the controls varied among the hospitals, with trauma accounting for the largest fraction in Phoenix (35 percent), circulatory diseases in Boston (29 percent), and musculoskeletal diseases in Pittsburgh (41 percent). The patients with tumors tended to be older than the controls, more highly educated, and from homes with higher household incomes (Table 1); these differences were most pronounced in the patients with acoustic neuromas.

Among the controls, 232 (29 percent) reported having used a hand-held cellular telephone more than five times; the proportion who reported use at that level was 29 percent among patients hospitalized with trauma, 22 percent among those with circulatory disease, 31 percent among those with musculoskeletal disorders, and 33 percent among other patients. The proportion of controls who reported having used a hand-held cellular telephone more than five times increased during the course of the study, whereas the corresponding proportions for the use of car phones and transportable cellular telephones did not (Figure 1AFigure 1Percentage of Controls Who Had Used a Cellular Telephone More Than Five Times, According to the Year of the Interview and Type of Cellular Telephone (Panel A), Age at the Time of the Interview and Sex (Panel B), Self-Reported Annual Household Income (Panel C), and Level of Education (Panel D).). Use of hand-held cellular telephones was higher among men than among women, decreased with age for both sexes (but more so for women), and was positively associated with self-reported household income and educational level (Figure 1B, 1C, and 1D). The lower prevalence of use among patients with circulatory disease reflects their older age (mean, 57 years, as compared with 47 years for other controls).

Risk According to Level of Use

Neither ever having used a hand-held cellular telephone nor regular use of one was significantly associated with the relative risk of glioma, meningioma, or acoustic neuroma (Table 2Table 2Relative Risks of Different Types of Intracranial Tumor of the Nervous System, According to the Level of Use of Hand-Held Cellular Telephones.). Among regular users, relative risks were not higher among those who began using cellular telephones in earlier years, nor did the risk of any type of tumor increase significantly with increasing duration of use, frequency of use, or total cumulative use (Table 2).

Seventeen patients with tumors and 28 controls reported having used hand-held cellular telephones for an average of 15 or more minutes per day for at least three years. The distribution of these patients according to histologic type of tumor was as follows: four had anaplastic astrocytoma, three had glioblastoma, one had astrocytoma, one had oligodendroglioma, one had ependymoma, two had an unspecified type of glioma, four had meningioma, and one had acoustic neuroma. The relative risk for glioma at this level of cellular-telephone use was 0.7 (95 percent confidence interval, 0.3 to 1.6).

Significantly elevated relative risks were not observed for any of the hospitals, for either sex, or for any age groups, and there was little heterogeneity in risk among subgroups of the controls (data not shown). For glioma, the relative risk associated with using a cellular telephone more than five times as compared with never using one was 1.2 when the control group used in the analysis was limited to persons admitted because of injuries; the relative risk was 1.0 when the subgroup was those admitted for circulatory diseases; 1.0 when the subgroup was those admitted for musculoskeletal diseases; and 0.9 when the subgroup was those admitted for other illnesses or conditions.

The relative risks were not significantly increased for subcategories of glioma defined according to histologic type, grade, laterality, or affected lobe of the brain (Table 3Table 3Relative Risks of Glioma and Neuroepitheliomatous Tumors Associated with the Use of Hand-Held Cellular Telephones More Than Five Times, as Compared with No Use.). Estimated relative risks were 1.1 for all astrocytic tumors combined and 0.9 for high-grade astrocytoma. Within the latter category, the relative risk was nonsignificantly greater than 1.0 for anaplastic astrocytoma and nonsignificantly less than 1.0 for glioblastoma. The relative risk of anaplastic astrocytoma was greater for persons who had used cellular telephones one to five times in their lives (relative risk, 2.6) than for persons who had used them more than five times (relative risk, 1.8).

Additional covariates (marital status, religion, type of health insurance, history of radiotherapy to the head or neck, and handedness) had little or no influence on the estimates of relative risk, nor did age when age categories smaller than 10 years were used. Patients with glioma were interviewed, on average, four months earlier than controls, but the analysis was adjusted for the date of the interview, so the trend over time in the use of cellular telephones was taken into account.

Laterality of Tumor and of Telephone Use

Among patients with tumors who reported having used hand-held cellular telephones regularly for at least six months before diagnosis, the laterality of the tumor was not significantly associated with the self-reported laterality of use of the cellular telephone (Table 4Table 4Laterality of Tumor with Respect to Laterality of Telephone Use among Patients with Brain Tumors with Regular Use of a Hand-Held Cellular Telephone for at Least Six Months before Diagnosis.). Relative risks of gliomas involving the frontal, temporal, and parietal lobes were 1.0 (P=1.00), 0.9 (P=0.66), and 0.8 (P=0.55), respectively, and the relative risk of anaplastic astrocytoma was 1.2 (P=1.00).

Discussion

Our results do not substantiate the concern that some brain tumors diagnosed in the United States during the mid-1990s were caused by the use of hand-held cellular telephones. There was little or no indication of an increased risk of glioma, meningioma, or acoustic neuroma associated with any use, cumulative use, or the laterality of use of these telephones. There was no significantly increased risk associated with the use of cellular telephones at any of the three centers, and estimates of the relative risk associated with the use of cellular telephones were insensitive to the inclusion or exclusion of any of the four principal subgroups of controls.

Some degree of misclassification of patients' relative levels of exposure was inevitable, because of inherent limitations in the ability of the interview to capture historical changes in a patient's pattern of cellular telephone use, inaccuracies in patients' recall, and variations in the levels of exposure to microwave radiation with different types of hand-held cellular telephones and under different circumstances of use. In a previous study,29 a good correlation (Spearman's r=0.79) was reported between the self-reported use of cellular telephones and billing records from cellular-telephone companies. Patients with gliomas sometimes have impairments of memory or cognition that might compromise their ability to report past events and habits as accurately as healthy persons. Such impairment is considerably less common among young and middle-aged patients with gliomas than among elderly patients and is uncommon among patients with meningiomas or acoustic neuromas.26 Cellular-telephone use was much more common among persons less than 70 years old than among those 70 years old or older (Figure 1B). If cellular telephones cause brain tumors, and the induction period is not long, one would expect the effect to be evident among case patients younger than the ages at which aphasia is a common symptom. It was not.

In addition to the frequency and duration of telephone use, factors that can affect the level of exposure to microwave radiation include the distance from the base station, the local topography and vegetation, whether the phone is used indoors or outdoors, the design of the particular model of telephone, and the position of the antenna and the telephone in relation to the head.8,20,30,31 Failure to account for these variables could result in the misclassification of the level of exposure, but these factors are unlikely to vary systematically with the frequency or duration of use. The misclassification of the level of use is more likely than the misclassification of use itself, and the low overall risk among regular users suggests that if the study failed to detect a substantially elevated risk, it was confined to a small subgroup.

Microwave radiation is attenuated rapidly with passage though tissue, so that the absorption of energy by tissue 5 cm below the surface of the skin is less than 10 percent of that at the surface, and absorption is an order of magnitude less on the side of the head opposite that on which the telephone is used than it is on the side of use.1,4,20,31-34 However, we found no positive associations between the laterality of the tumor and the side of cellular-telephone use for any of the principal categories of tumors. It is difficult to assess correlations between the location of the tumor and the deposition of microwave energy at a finer gradation than laterality, insofar as the pattern of energy absorption is sensitive even to small changes in the position and design of the telephone32,35 and the precise origin of the tumor is unknown. Parts of the temporal, parietal, and occipital lobes have been described as regions of relatively high exposure, whereas the frontal lobe is generally considered to be much less exposed.1,4,6,34 We found no evidence that cellular-telephone use was more strongly associated with gliomas in the temporal or parietal lobe than it was with gliomas in the frontal lobe.

The most important limitation of our study is its limited precision for assessing the risks after a potential induction period of more than several years or among people with very high levels of daily or cumulative use. For example, we cannot rule out a 60 percent increase in the risk of glioma associated with cumulative use of 100 hours or more. If an effect of cellular telephones was limited to a relatively uncommon type of tumor, or to a very small volume of highly exposed tissue immediately adjacent to the handset, a much larger sample would be required to detect it. The study was designed to have adequate power to assess the relative risk of all gliomas combined, but not for subtypes of glioma.

There have been substantial changes in wireless communication technology since this study began in 1993. The current trend is toward greater use of digital technology and higher frequencies of transmission.8,20,36-38 Because of the timing of this study, we presume that our results pertain primarily to analogue telephones with frequencies of 800 to 900 MHz. Digital telephones operate at a lower average power than analogue telephones,4,8 and we would not expect them to carry a higher risk, unless there is an important aspect of exposure other than the rate of energy deposition. No increase in the risk of brain tumors associated with the use of analogue or digital cellular telephones was found in a small, case–control study conducted in Sweden.6 Multicenter, international studies that are just getting under way39,40 will have greater statistical power to assess the risks of cancer associated with long induction periods and will provide information about the risks associated with the use of digital telephones.

Our results do not support the view that exposure to low-power microwave radiation from hand-held, analogue cellular telephones causes malignant or benign tumors of the brain or nervous system. However, given the fact that widespread use of cellular telephones is a recent development, the dramatic increases that have occurred in the frequency of use, and the changes in cellular technology over time, the findings should be seen as an estimate of the risk at an early stage of the use of this technology.

NAPS See the Appendix or NAPS document no. 05579 for 2 pages of supplementary material. To order the NAPS document, contact NAPS, c/o Microfiche Publications, 248 Hempstead Tpke., West Hempstead, NY 11552.

We are indebted to our external advisory panel for their thoughtful comments and advice concerning the manuscript; to Emily Khoury, Brian Paul, Patsy Thompson, Donna Houpt, Kelli Williamson, Sandra McGuire, Renee Karlsen, Patricia Yost, Janice Whelan, Douglas Watson, Diane Fuchs, Bob Saal, Christel McCarty, George Geise, and Rebecca Albert for their valuable and dedicated assistance during the conduct of the study; and to the University of North Carolina Hospitals for providing the opportunity to pretest study instruments and procedures on a sample of neurosurgical patients.

Source Information

From the Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics (P.D.I., R.E.T., E.E.H., M.S.L.), and the Neuro-Oncology Branch (H.A.F.), National Cancer Institute, Bethesda, Md.; the Epidemiology and Medical Studies Program, Research Triangle Institute, Research Triangle Park, N.C. (T.C.W.); the Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Ariz. (W.R.S.); the Division of Neurosurgery, Western Pennsylvania Hospital, Pittsburgh (R.G.S.); Brigham and Women's Hospital, Boston (P.M.B.); and the Department of Radiation Oncology, Massachusetts General Hospital, Boston (J.S.L.).

Address reprint requests to Dr. Inskip at Executive Plaza S., Rm. 7052, 6120 Executive Blvd., Rockville, MD 20852, or at .

Appendix

In the following analysis, B denotes brain tumor, P cellular-telephone use, R right side, L left side, and Pr probability. The usual estimate of the odds ratio from a two-by-two table for laterality like those in Table 4 is an estimate of the quantity

[Pr(BR|PR)Pr(BL|PL)]÷[Pr(BL|PR)Pr(BR|PL)],

where, for example, Pr(BR|PR) is the probability of the development of a brain tumor on the right side of the brain when the cellular telephone was used on the right side. If cellular-telephone use is independent of the risk of brain tumors, then

Pr(BR|PR)=Pr(BR|PL)=Pr(BR) and Pr(BL|PL)=Pr(BL|PR)=Pr(BL),

so that the odds ratio is always 1.0, even though there may be a higher probability that a tumor will develop on one side of the brain than the other.

Suppose that cellular-telephone use is associated with brain tumors and that the relative risk that a tumor will develop on the side of cellular-telephone use is the same for tumors on the left side and on the right side. That is, assume that

Pr(BL|PL)=Υ Pr(BL|PR) and Pr(BR|PR)=Υ Pr(BR|PL).

It follows that the usual odds ratio estimated from a two-by-two table for laterality is an estimate of Υ2, and thus that the square root of the odds ratio is an estimate of Υ. If cellular-telephone use does not expose the side of the brain opposite the side of use to any radiation, then the laterality risk ratio, Υ, quantifies the risk of brain tumors due to cellular-telephone use.

The relative risk for the general population is defined as

RR=P(B|P)÷P(B|no P),

where brain tumors and cellular-telephone exposure can occur on either side of the brain. Assume that brain tumors are equally likely on the left and the right side in the absence of cellular-telephone exposure. Then it follows that

Pr(B|no P)=Pr(BR|no P)+Pr(BL|no P)=2Pr(BR|no P)=2 Pr(BR|PL)=2 Pr(BL|PR).

Assuming, without loss of generality, that cellular-telephone use is on the left side, it follows that

Pr(B|P)=Pr(B|PL)=Pr(BL|PL)+Pr(BR|PL),

and thus that RR=(Υ+1)÷2.

This Appendix appears only with the electronic version of the article.

References

References

  1. 1

    Balzano Q, Garay O, Manning TJ Jr. Electromagnetic energy exposure of simulated users of portable cellular telephones. IEEE Trans Veh Technol 1995;44:390-403
    CrossRef | Web of Science

  2. 2

    How many people use wireless phones? Washington, D.C.: Cellular Telecommunication Industry Association, 2000. (See http://www.wow-com. com/consumer/faqs/faq_general.cfm#one.) (See NAPS document no. 05580 for 3 pages, c/o Microfiche Publications, 248 Hempstead Tpke., West Hempstead, NY 11552.)

  3. 3

    Maier M, Blakemore C, Koivisto M. The health hazards of mobile phones. BMJ 2000;320:1288-1289
    CrossRef | Web of Science | Medline

  4. 4

    Rothman KJ, Chou CK, Morgan R, et al. Assessment of cellular telephone and other radio frequency exposure for epidemiologic research.Epidemiology 1996;7:291-8.

  5. 5

    McKinlay A. Possible health effects related to the use of radiotelephones: recommendations of a European Commission Expert Group. Radiol Prot Bull 1997;187:9-16

  6. 6

    Hardell L, Nasman A, Pahlson A, Hallquist A, Hansson Mild K. Use of cellular telephones and the risk for brain tumours: a case-control study. Int J Oncol 1999;15:113-116
    Web of Science | Medline

  7. 7

    Moulder JE, Erdreich LS, Malyapa RS, Merritt J, Pickard WF, Vijayalaxmi. Cell phones and cancer: what is the evidence for a connection? Radiat Res 1999;151:513-531
    CrossRef | Web of Science | Medline

  8. 8

    Independent Expert Group on Mobile Phones. Mobile phones and health. Chilton, England: National Radiological Protection Board, 2000.

  9. 9

    Hermann DM, Hossmann K-A. Neurological effects of microwave exposure related to mobile communication. J Neurol Sci 1997;152:1-14
    CrossRef | Web of Science | Medline

  10. 10

    Anderson V, Joyner KH. Specific absorption rate levels measured in a phantom head exposed to radio frequency transmissions from analog hand-held mobile phones. Bioelectromagnetics 1995;16:60-69
    CrossRef | Web of Science | Medline

  11. 11

    Valberg PA. Radio frequency radiation (RFR): the nature of exposure and carcinogenic potential. Cancer Causes Control 1997;8:323-332
    CrossRef | Web of Science | Medline

  12. 12

    Van Leeuwen GMJ, Lagendijk JJW, Van Leersum BJAM, Zwamborn APM, Hornsleth SN, Kotte ANTJ. Calculation of change in brain temperatures due to exposure to a mobile phone. Phys Med Biol 1999;44:2367-2379
    CrossRef | Web of Science | Medline

  13. 13

    Adey WR. Bioeffects of mobile communications fields: possible mechanisms for cumulative dose. In: Kuster N, Balzano Q, Lin JC, eds. Mobile communications safety. New York: Chapman & Hall, 1997:95-131.

  14. 14

    Meltz ML, Walker KA, Erwin DN. Radiofrequency (microwave) radiation exposure of mammalian cells during UV-induced DNA repair synthesis. Radiat Res 1987;110:255-266
    CrossRef | Web of Science | Medline

  15. 15

    Brusick D, Albertini R, McRee D, et al. Genotoxicity of radiofrequency radiation. Environ Mol Mutagen 1998;32:1-16
    CrossRef | Web of Science | Medline

  16. 16

    Malyapa RS, Ahern EW, Straube WL, Moros EG, Pickard WF, Roti Roti JL. Measurement of DNA damage after exposure to electromagnetic radiation in the cellular phone communication frequency band (835.62 and 847.74 MHz). Radiat Res 1997;148:618-627
    CrossRef | Web of Science | Medline

  17. 17

    Dreyer NA, Loughlin JE, Rothman KJ. Cause-specific mortality in cellular telephone users. JAMA 1999;282:1814-1816
    CrossRef | Web of Science | Medline

  18. 18

    Elwood J. A critical review of epidemiologic studies of radiofrequency exposure and human cancers. Environ Health Perspect 1999;107:Suppl 1:155-168
    CrossRef | Web of Science | Medline

  19. 19

    Morgan RW, Kelsh MA, Zhao K, Exuzides KA, Heringer S, Negrete W. Radiofrequency exposure and mortality from cancer of the brain and lymphatic/hematopoietic systems. Epidemiology 2000;11:118-127
    CrossRef | Web of Science | Medline

  20. 20

    International Commission on Non-Ionizing Radiation Protection. Health issues related to the use of hand-held radiotelephones and base transmitters. Health Phys 1996;70:587-593
    Web of Science | Medline

  21. 21

    Repacholi MH. Low-level exposure to radiofrequency electromagnetic fields: health effects and research needs. Bioelectromagnetics 1998;19:1-19
    CrossRef | Web of Science | Medline

  22. 22

    Electromagnetic fields (300 Hz to 300 GHz). Geneva: World Health Organization, 1993.

  23. 23

    Inskip PD, Hatch EE, Stewart PA, et al. Study design for a case-control investigation of cellular telephones and other risk factors for brain tumors in adults. Radiat Prot Dosim 1999;86:45-52
    Web of Science

  24. 24

    Percy C, Van Holten V, Muir C, eds. International classification of diseases for oncology, 2nd ed.: ICD-O. Geneva: World Health Organization, 1990.

  25. 25

    Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993;3:255-268
    CrossRef | Web of Science | Medline

  26. 26

    Kleihues P, Cavenee WK. Pathology and genetics of tumours of the nervous system. Lyon, France: International Agency for Research on Cancer, 1997.

  27. 27

    Lubin JH. A computer program for the analysis of matched case-control studies. Comput Biomed Res 1981;14:138-143
    CrossRef | Medline

  28. 28

    Preston DL, Lubin JH, Pierce DA, McConney ME. Epicure users guide. Seattle: Hirosoft International, 1993.

  29. 29

    Funch DP, Rothman KJ, Loughlin JE, Dreyer NA. Utility of telephone company records for epidemiologic studies of cellular telephones. Epidemiology 1996;7:299-302
    CrossRef | Web of Science | Medline

  30. 30

    Cleveland RF Jr, Athey TW. Specific absorption rate (SAR) in models of the human head exposed to hand-held UHF portable radios. Bioelectromagnetics 1989;10:173-186
    CrossRef | Web of Science | Medline

  31. 31

    Balzano Q. Exposure metrics for RF epidemiology: cellular phone handsets. Radiat Prot Dosim 1999;83:165-169
    Web of Science

  32. 32

    Gandhi O. Some numerical methods for dosimetry: extremely low frequencies to microwave frequencies. Radio Sci 1995;30:161-177
    CrossRef | Web of Science

  33. 33

    Dimbylow PJ, Mann SM. sar calculations in an anatomically realistic model of the head for mobile communication transceivers at 900 MHz and 1.8 GHz. Phys Med Biol 1994;39:1537-1553
    CrossRef | Web of Science | Medline

  34. 34

    Dimbylow P, Mann SM. Characterization of energy deposition in the head from cellular phones. Radiat Prot Dosim 1999;83:139-141
    Web of Science

  35. 35

    Kuster N, Balzano Q. Experimental and numerical dosimetry. In: Kuster N, Balzano Q, Lin JC, eds. Mobile communications safety. New York: Chapman & Hall, 1997:13-64.

  36. 36

    Dreyer NA, Loughlin JE, Rothman KJ. Epidemiological safety surveillance of cellular telephones in the US. Radiat Prot Dosim 1999;83:159-163
    Web of Science

  37. 37

    Ramsdale PA, Wiener A. Cellular phone base stations: technology and exposures. Radiat Prot Dosim 1999;83:125-130
    Web of Science

  38. 38

    Millington RJ. Mobile and personal communications in the 90s. In: Kuster N, Balzano Q, Lin JC, eds. Mobile communications safety. New York: Chapman & Hall, 1997:3-9.

  39. 39

    Of mobile phones and morbidity. Environ Health Perspect 1998;106:A474-A475
    CrossRef | Web of Science | Medline

  40. 40

    Cardis E, Kilkenny M. International case-control study of adult brain, head and neck tumours: results of the feasibility study. Radiat Prot Dosim 1999;83:179-183
    Web of Science

Citing Articles (141)

Citing Articles

  1. 1

    Samer Ayoubi, Ian F. Dunn, Ossama Al-Mefty. 2012. Meningiomas. , 600-629.
    CrossRef

  2. 2

    Atom Sarkar, E. Antonio Chiocca. 2012. Glioblastoma and malignant astrocytoma. , 384-407.
    CrossRef

  3. 3

    Katherine E. Warren, Russell R. Lonser. 2012. Brainstem tumors. , 424-434.
    CrossRef

  4. 4

    Isabelle Deltour, Anssi Auvinen, Maria Feychting, Christoffer Johansen, Lars Klaeboe, Risto Sankila, Joachim Schüz. (2012) Mobile Phone Use and Incidence of Glioma in the Nordic Countries 1979–2008. Epidemiology1
    CrossRef

  5. 5

    Kavindra Kumar Kesari, Sanjay Kumar, Jitendra Behari. (2011) 900-MHz microwave radiation promotes oxidation in rat brain. Electromagnetic Biology and Medicine 30:4, 219-234
    CrossRef

  6. 6

    (2011) Acoustic neuroma risk in relation to mobile telephone use: Results of the INTERPHONE international case–control study. Cancer Epidemiology 35:5, 453-464
    CrossRef

  7. 7

    Y. Duan, H.Z. Zhang, R.F. Bu. (2011) Correlation between cellular phone use and epithelial parotid gland malignancies. International Journal of Oral and Maxillofacial Surgery 40:9, 966-972
    CrossRef

  8. 8

    E. H. Nielsen, U. Feldt-Rasmussen, L. Poulsgaard, L. Ø. Kristensen, J. Astrup, J. O. Jørgensen, P. Bjerre, M. Andersen, C. Andersen, J. Jørgensen, J. Lindholm, P. Laurberg. (2011) Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. Journal of Neuro-Oncology 104:3, 755-763
    CrossRef

  9. 9

    J. D. Boice, R. E. Tarone. (2011) Cell Phones, Cancer, and Children. JNCI Journal of the National Cancer Institute 103:16, 1211-1213
    CrossRef

  10. 10

    Matthias Preusser, Sandrine de Ribaupierre, Adelheid Wöhrer, Sara C. Erridge, Monika Hegi, Michael Weller, Roger Stupp. (2011) Current concepts and management of glioblastoma. Annals of Neurology 70:1, 9-21
    CrossRef

  11. 11

    Anthony J. Swerdlow, Maria Feychting, Adele C. Green, Leeka Kheifets, David A. Savitz, . (2011) Mobile Phones, Brain Tumors, and the Interphone Study: Where Are We Now?. Environmental Health Perspectives 119:11, 1534-1538
    CrossRef

  12. 12

    Robert Baan, Yann Grosse, Béatrice Lauby-Secretan, Fatiha El Ghissassi, Véronique Bouvard, Lamia Benbrahim-Tallaa, Neela Guha, Farhad Islami, Laurent Galichet, Kurt Straif. (2011) Carcinogenicity of radiofrequency electromagnetic fields. The Lancet Oncology 12:7, 624-626
    CrossRef

  13. 13

    Or Cohen-Inbar, Gil E. Sviri, Jean F. Soustiel, Menashe Zaaroor. (2011) The Geriatric Scoring System (GSS) in meningioma patients—validation. Acta Neurochirurgica 153:7, 1501-1508
    CrossRef

  14. 14

    Denis Aydin, Maria Feychting, Joachim Schüz, Tina Veje Andersen, Aslak Harbo Poulsen, Michaela Prochazka, Lars Klaeboe, Claudia E. Kuehni, Tore Tynes, Martin Röösli. (2011) Impact of random and systematic recall errors and selection bias in case-control studies on mobile phone use and brain tumors in adolescents (CEFALO study). Bioelectromagnetics 32:5, 396-407
    CrossRef

  15. 15

    Subhojit Dey, Zhenzhen Zhang, Ahmed Hablas, Ibrahim A. Seifeldein, Mohamed Ramadan, Hesham El-Hamzawy, Amr S. Soliman. (2011) Geographic patterns of cancer in the population-based registry of Egypt: Possible links to environmental exposures. Cancer Epidemiology 35:3, 254-264
    CrossRef

  16. 16

    Quinn T. Ostrom, Jill S. Barnholtz-Sloan. (2011) Current State of Our Knowledge on Brain Tumor Epidemiology. Current Neurology and Neuroscience Reports 11:3, 329-335
    CrossRef

  17. 17

    Yasuto Sato, Suminori Akiba, Osami Kubo, Naohito Yamaguchi. (2011) A case-case study of mobile phone use and acoustic neuroma risk in Japan. Bioelectromagnetics 32:2, 85-93
    CrossRef

  18. 18

    Steven Lehrer, Sheryl Green, Richard G. Stock. (2011) Association between number of cell phone contracts and brain tumor incidence in nineteen U.S. States. Journal of Neuro-Oncology 101:3, 505-507
    CrossRef

  19. 19

    Ikuharu MORIOKA, Yuna TABUCHI, Yuko TAKAHASHI, Yuriko ODA, Masami NAKAI, Aki YANASE, Chiyoko WATAZU. (2011) Bacterial Contamination of Mobile Phones Shared in Hospital Wards and the Consciousness and Behavior of Nurses about Biological Cleanliness. Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene) 66:1, 115-121
    CrossRef

  20. 20

    Angelo G Levis, Nadia Minicuci, Paolo Ricci, Valerio Gennaro, Spiridione Garbisa. (2011) Mobile phones and head tumours. The discrepancies in cause-effect relationships in the epidemiological studies - how do they arise?. Environmental Health 10:1, 59
    CrossRef

  21. 21

    Michael H. Repacholi, Alexander Lerchl, Martin Röösli, Zenon Sienkiewicz, Anssi Auvinen, Jürgen Breckenkamp, Guglielmo d'Inzeo, Paul Elliott, Patrizia Frei, Sabine Heinrich, Isabelle Lagroye, Anna Lahkola, David L. McCormick, Silke Thomas, Paolo Vecchia. (2011) Systematic review of wireless phone use and brain cancer and other head tumors. Bioelectromagneticsn/a-n/a
    CrossRef

  22. 22

    Jonathan M Samet. (2011) Radiation and cancer risk: a continuing challenge for epidemiologists. Environmental Health 10:Suppl 1, S4
    CrossRef

  23. 23

    Mona Shum, Michael A. Kelsh, Asher R. Sheppard, Ke Zhao. (2011) An evaluation of self-reported mobile phone use compared to billing records among a group of engineers and scientists. Bioelectromagnetics 32:1, 37-48
    CrossRef

  24. 24

    Rash Bihari Dubey, Madasu Hanmandlu, Suresh Kumar Gupta. (2010) Risk of Brain Tumors From Wireless Phone Use. Journal of Computer Assisted Tomography 34:6, 799-807
    CrossRef

  25. 25

    Joseph Wiemels, Margaret Wrensch, Elizabeth B. Claus. (2010) Epidemiology and etiology of meningioma. Journal of Neuro-Oncology 99:3, 307-314
    CrossRef

  26. 26

    Pierre Giglio, John Lee Villano. (2010) Newly Diagnosed High-Grade Gliomas. Current Treatment Options in Neurology 12:4, 309-320
    CrossRef

  27. 27

    (2010) Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. International Journal of Epidemiology 39:3, 675-694
    CrossRef

  28. 28

    Dhiraj Maskey, Minsoo Kim, Bijay Aryal, Jonu Pradhan, In-Young Choi, Ki-Sup Park, Taeho Son, Sae-Yong Hong, Seok Bae Kim, Hyung Gun Kim, Myeung Ju Kim. (2010) Effect of 835 MHz radiofrequency radiation exposure on calcium binding proteins in the hippocampus of the mouse brain. Brain Research 1313, 232-241
    CrossRef

  29. 29

    Lisa Calvocoressi, Elizabeth B. Claus. 2010. Epidemiology and Natural History of Meningiomas. , 61-77.
    CrossRef

  30. 30

    P. Rajaraman, A. Hutchinson, S. Wichner, P. M. Black, H. A. Fine, J. S. Loeffler, R. G. Selker, W. R. Shapiro, N. Rothman, M. S. Linet, P. D. Inskip. (2010) DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro-Oncology 12:1, 37-48
    CrossRef

  31. 31

    Adelheid Wöhrer, Thomas Waldhör, Harald Heinzl, Monika Hackl, Johann Feichtinger, Ulrike Gruber-Mösenbacher, Andreas Kiefer, Hans Maier, Reinhard Motz, Angelika Reiner-Concin, Bernd Richling, Carmen Idriceanu, Michael Scarpatetti, Roland Sedivy, Hans-Christian Bankl, Wolfgang Stiglbauer, Matthias Preusser, Karl Rössler, Johannes Andreas Hainfellner. (2009) The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. Journal of Neuro-Oncology 95:3, 401-411
    CrossRef

  32. 32

    Joachim Schüz, Susanna Lagorio, Ferdinando Bersani. (2009) Electromagnetic fields and epidemiology: An overview inspired by the fourth course at the International School of Bioelectromagnetics. Bioelectromagnetics 30:7, 511-524
    CrossRef

  33. 33

    Yoko Mizuno, Yoshiya Moriguchi, Takashi Hikage, Yasuo Terao, Takashi Ohnishi, Toshio Nojima, Yoshikazu Ugawa. (2009) Effects of W-CDMA 1950 MHz EMF emitted by mobile phones on regional cerebral blood flow in humans. Bioelectromagnetics 30:7, 536-544
    CrossRef

  34. 34

    Yueh-Ying Han, Hideyuki Kano, Devra L. Davis, Ajay Niranjan, L. Dade Lunsford. (2009) Cell phone use and acoustic neuroma: the need for standardized questionnaires and access to industry data. Surgical Neurology 72:3, 216-222
    CrossRef

  35. 35

    Vini G. Khurana, Charles Teo, Michael Kundi, Lennart Hardell, Michael Carlberg. (2009) Cell phones and brain tumors: a review including the long-term epidemiologic data. Surgical Neurology 72:3, 205-214
    CrossRef

  36. 36

    Anders Ahlbom, Maria Feychting, Adele Green, Leeka Kheifets, David A. Savitz, Anthony J. Swerdlow. (2009) Epidemiologic Evidence on Mobile Phones and Tumor Risk. Epidemiology 20:5, 639-652
    CrossRef

  37. 37

    Paolo Galloni, Vanni Lopresto, Marta Parazzini, Rosanna Pinto, Marta Piscitelli, Paolo Ravazzani, Carmela Marino. (2009) No effects of UMTS exposure on the function of rat outer hair cells. Bioelectromagnetics 30:5, 385-392
    CrossRef

  38. 38

    Martine Vrijheid, Bruce K Armstrong, Daniel Bédard, Julianne Brown, Isabelle Deltour, Ivano Iavarone, Daniel Krewski, Susanna Lagorio, Stephen Moore, Lesley Richardson, Graham G Giles, Mary Mcbride, Marie-Elise Parent, Jack Siemiatycki, Elisabeth Cardis. (2009) Recall bias in the assessment of exposure to mobile phones. Journal of Exposure Science and Environmental Epidemiology 19:4, 369-381
    CrossRef

  39. 39

    Orhan Bas, Ersan Odaci, Suleyman Kaplan, Niyazi Acer, Kagan Ucok, Serdar Colakoglu. (2009) 900 MHz electromagnetic field exposure affects qualitative and quantitative features of hippocampal pyramidal cells in the adult female rat. Brain Research 1265, 178-185
    CrossRef

  40. 40

    Belinda A. Campbell, Ashu Jhamb, John A. Maguire, Brian Toyota, Roy Ma. (2009) Meningiomas in 2009. American Journal of Clinical Oncology 32:1, 73-85
    CrossRef

  41. 41

    R. J. Croft, R. J. McKenzie, I. Inyang, G. P. Benke, V. Anderson, M. J. Abramson. (2008) Mobile phones and brain tumours: a review of epidemiological research. Australasian Physics & Engineering Sciences in Medicine 31:4, 255-267
    CrossRef

  42. 42

    L. Kheifets, S. Oksuzyan. (2008) Exposure assessment and other challenges in non-ionizing radiation studies of childhood leukaemia. Radiation Protection Dosimetry 132:2, 139-147
    CrossRef

  43. 43

    A. E. Kaprana, A. D. Karatzanis, E. P. Prokopakis, I. E. Panagiotaki, I. O. Vardiambasis, G. Adamidis, P. Christodoulou, G. A. Velegrakis. (2008) Studying the effects of mobile phone use on the auditory system and the central nervous system: a review of the literature and future directions. European Archives of Oto-Rhino-Laryngology 265:9, 1011-1019
    CrossRef

  44. 44

    Wen, Patrick Y., Kesari, Santosh, . (2008) Malignant Gliomas in Adults. New England Journal of Medicine 359:5, 492-507
    Full Text

  45. 45

    T Takebayashi, N Varsier, Y Kikuchi, K Wake, M Taki, S Watanabe, S Akiba, N Yamaguchi. (2008) Mobile phone use, exposure to radiofrequency electromagnetic field, and brain tumour: a case–control study. British Journal of Cancer 98:3, 652-659
    CrossRef

  46. 46

    A Lahkola, T Salminen, J Raitanen, S Heinavaara, M. Schoemaker, H C. Christensen, M Feychting, C Johansen, L Klaeboe, S Lonn, A. Swerdlow, T Tynes, A Auvinen. (2008) Meningioma and mobile phone use--a collaborative case-control study in five North European countries. International Journal of Epidemiology 37:6, 1304-1313
    CrossRef

  47. 47

    Nadège Varsier, Kanako Wake, Masao Taki, Soichi Watanabe, Toru Takebayashi, Naohito Yamaguchi, Yuriko Kikuchi. (2008) SAR characterization inside intracranial tumors for case–control epidemiological studies on cellular phones and RF exposure. annals of telecommunications - annales des télécommunications 63:1-2, 65-78
    CrossRef

  48. 48

    Michael Kundi. (2008) The Controversy about a Possible Relationship between Mobile Phone Use and Cancer. Environmental Health Perspectives
    CrossRef

  49. 49

    Vini G. Khurana, John E. Moulder, Colin G. Orton. (2008) There is currently enough evidence and technology available to warrant taking immediate steps to reduce exposure of consumers to cell-phone-related electromagnetic radiation. Medical Physics 35:12, 5203
    CrossRef

  50. 50

    Tae-Hyoung Kim, Tai-Qin Huang, Ja-June Jang, Man Ho Kim, Hyun-Jeong Kim, Jae-Seon Lee, Jeong Ki Pack, Jeong-Sun Seo, Woong-Yang Park. (2008) Local exposure of 849 MHz and 1763 MHz radiofrequency radiation to mouse heads does not induce cell death or cell proliferation in brain. Experimental and Molecular Medicine 40:3, 294
    CrossRef

  51. 51

    Peter Kan, Sara E. Simonsen, Joseph L. Lyon, John R. W. Kestle. (2008) Cellular phone use and brain tumor: a meta-analysis. Journal of Neuro-Oncology 86:1, 71-78
    CrossRef

  52. 52

    Jill S. Barnholtz-Sloan, Carol Kruchko. (2007) Meningiomas: causes and risk factors. Neurosurgical FOCUS 23:4, E2
    CrossRef

  53. 53

    Tomoyuki Shirai, Toshio Ichihara, Kanako Wake, So-ichi Watanabe, Yukio Yamanaka, Mayumi Kawabe, Masao Taki, Osamu Fujiwara, Jianqing Wang, Satoru Takahashi, Seiko Tamano. (2007) Lack of promoting effects of chronic exposure to 1.95-GHz W-CDMA signals for IMT-2000 cellular system on development of N-ethylnitrosourea-induced central nervous system tumors in F344 rats. Bioelectromagnetics 28:7, 562-572
    CrossRef

  54. 54

    Elisabeth Cardis, Lesley Richardson, Isabelle Deltour, Bruce Armstrong, Maria Feychting, Christoffer Johansen, Monique Kilkenny, Patricia McKinney, Baruch Modan, Siegal Sadetzki, Joachim Schüz, Anthony Swerdlow, Martine Vrijheid, Anssi Auvinen, Gabriele Berg, Maria Blettner, Joseph Bowman, Julianne Brown, Angela Chetrit, Helle Collatz Christensen, Angus Cook, Sarah Hepworth, Graham Giles, Martine Hours, Ivano Iavarone, Avital Jarus-Hakak, Lars Klaeboe, Daniel Krewski, Susanna Lagorio, Stefan Lönn, Simon Mann, Mary McBride, Kenneth Muir, Louise Nadon, Marie-Elise Parent, Neil Pearce, Tiina Salminen, Minouk Schoemaker, Brigitte Schlehofer, Jack Siemiatycki, Masao Taki, Toru Takebayashi, Tore Tynes, Martie Tongeren, Paolo Vecchia, Joe Wiart, Alistair Woodward, Naohito Yamaguchi. (2007) The INTERPHONE study: design, epidemiological methods, and description of the study population. European Journal of Epidemiology 22:9, 647-664
    CrossRef

  55. 55

    Linda S. Erdreich, Maria D. Van Kerkhove, Carolyn G. Scrafford, Leila Barraj, Mark McNeely, Mona Shum, Asher R. Sheppard, Michael Kelsh. (2007) Factors that Influence the Radiofrequency Power Output of GSM Mobile Phones. Radiation Research 168:2, 253-261
    CrossRef

  56. 56

    B. Schlehofer, K. Schlaefer, M. Blettner, G. Berg, E. Böhler, I. Hettinger, K. Kunna-Grass, J. Wahrendorf, J. Schüz. (2007) Environmental risk factors for sporadic acoustic neuroma (Interphone Study Group, Germany). European Journal of Cancer 43:11, 1741-1747
    CrossRef

  57. 57

    Daniel Krewski, Barry W. Glickman, Riadh W. Y. Habash, Brian Habbick, W. Gregory Lotz, Rosemonde Mandeville, Frank S. Prato, Tarek Salem, Donald F. Weaver. (2007) Recent Advances in Research on Radiofrequency Fields and Health: 2001–2003. Journal of Toxicology and Environmental Health, Part B 10:4, 287-318
    CrossRef

  58. 58

    Kari Tahvanainen, Juanita Niño, Pirjo Halonen, Tom Kuusela, Tommi Alanko, Tomi Laitinen, Esko Länsimies, Maila Hietanen, Harri Lindholm. (2007) Effects of cellular phone use on ear canal temperature measured by NTC thermistors. Clinical Physiology and Functional Imaging 27:3, 162-172
    CrossRef

  59. 59

    Anna Lahkola, Anssi Auvinen, Jani Raitanen, Minouk J. Schoemaker, Helle C. Christensen, Maria Feychting, Christoffer Johansen, Lars Klaeboe, Stefan Lönn, Anthony J. Swerdlow, Tore Tynes, Tiina Salminen. (2007) Mobile phone use and risk of glioma in 5 North European countries. International Journal of Cancer 120:8, 1769-1775
    CrossRef

  60. 60

    Joseph Gil Goldblatt, Iris Krief, Tal Klonsky, Daniel Haller, Victor Milloul, Diane M. Sixsmith, Isaac Srugo, Israel Potasman. (2007) Use of Cellular Telephones and Transmission of Pathogens by Medical Staff in New York and Israel • . Infection Control and Hospital Epidemiology 28:4, 500-503
    CrossRef

  61. 61

    Lars Klaeboe, Karl Gerhard Blaasaas, Tore Tynes. (2007) Use of mobile phones in Norway and risk of intracranial tumours. European Journal of Cancer Prevention 16:2, 158-164
    CrossRef

  62. 62

    Martin R????sli, Gisela Michel, Claudia E. Kuehni, Adrian Spoerri. (2007) Cellular telephone use and time trends in brain tumour mortality in Switzerland from 1969 to 2002. European Journal of Cancer Prevention 16:1, 77-82
    CrossRef

  63. 63

    Shin KOYAMA, Yoshio TAKASHIMA, Tomonori SAKURAI, Yukihisa SUZUKI, Masao TAKI, Junji MIYAKOSHI. (2007) Effects of 2.45 GHz Electromagnetic Fields with a Wide Range of SARs on Bacterial and HPRT Gene Mutations. Journal of Radiation Research 48:1, 69-75
    CrossRef

  64. 64

    M.J. Schoemaker, A.J. Swerdlow, A. Auvinen, H.C. Christensen, M. Feychting, C. Johansen, L. Klæboe, S. Lönn, T. Salminen, T. Tynes. (2007) Medical history, cigarette smoking and risk of acoustic neuroma: An international case-control study. International Journal of Cancer 120:1, 103-110
    CrossRef

  65. 65

    J. Schuz, R. Jacobsen, J. H. Olsen, J. D. Boice, J. K. McLaughlin, C. Johansen. (2006) Cellular Telephone Use and Cancer Risk: Update of a Nationwide Danish Cohort. JNCI Journal of the National Cancer Institute 98:23, 1707-1713
    CrossRef

  66. 66

    Anssi Auvinen, Tim Toivo, Kari Tokola. (2006) Epidemiological risk assessment of mobile phones and cancer: where can we improve?. European Journal of Cancer Prevention 15:6, 516-523
    CrossRef

  67. 67

    Martha S. Linet, Theresa Taggart, Richard K. Severson, James R. Cerhan, Wendy Cozen, Patricia Hartge, Joanne Colt. (2006) Cellular telephones and non-Hodgkin lymphoma. International Journal of Cancer 119:10, 2382-2388
    CrossRef

  68. 68

    San Ming Wang. (2006) Applying the SAGE technique to study the effects of electromagnetic field on biological systems. PROTEOMICS 6:17, 4765-4768
    CrossRef

  69. 69

    Lennart Hardell, Michael Carlberg, Kjell Hansson Mild. (2006) Pooled analysis of two case–control studies on use of cellular and cordless telephones and the risk for malignant brain tumours diagnosed in 1997–2003. International Archives of Occupational and Environmental Health 79:8, 630-639
    CrossRef

  70. 70

    Soo Chan Kim, Ki Chang Nam, Deok Won Kim. (2006) Estimation of relative exposure levels for cellular phone users using a neural network. Bioelectromagnetics 27:6, 440-444
    CrossRef

  71. 71

    J D Boice, J K McLaughlin. (2006) Concerning mobile phone use and risk of acoustic neuroma. British Journal of Cancer 95:1, 130-130
    CrossRef

  72. 72

    Martine Vrijheid, Isabelle Deltour, Daniel Krewski, Marie Sanchez, Elisabeth Cardis. (2006) The effects of recall errors and of selection bias in epidemiologic studies of mobile phone use and cancer risk. Journal of Exposure Science and Environmental Epidemiology 16:4, 371-384
    CrossRef

  73. 73

    Bernard C. Zook, Samuel J. Simmens. (2006) The Effects of Pulsed 860 MHz Radiofrequency Radiation on the Promotion of Neurogenic Tumors in Rats. Radiation Research 165:5, 608-615
    CrossRef

  74. 74

    M. Hours. (2006) Connaissances actuelles sur les relations entre le téléphone mobile et la santé. Archives des Maladies Professionnelles et de l'Environnement 67:2, 420-426
    CrossRef

  75. 75

    Sundeep Deorah, Charles F. Lynch, Zita A. Sibenaller, Timothy C. Ryken. (2006) Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurgical FOCUS 20:4, E1
    CrossRef

  76. 76

    Weijun Wang, Chien-Kuo Tai, Allan D. Kershaw, Sounkary K. Solly, David Klatzmann, Noriyuki Kasahara, Thomas C. Chen. (2006) Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model. Neurosurgical FOCUS 20:4, E25
    CrossRef

  77. 77

    P. Merola, C. Marino, G.A. Lovisolo, R. Pinto, C. Laconi, A. Negroni. (2006) Proliferation and apoptosis in a neuroblastoma cell line exposed to 900 MHz modulated radiofrequency field. Bioelectromagnetics 27:3, 164-171
    CrossRef

  78. 78

    Lennart Hardell, Michael Carlberg, Kjell Hansson Mild. (2006) Case–control study of the association between the use of cellular and cordless telephones and malignant brain tumors diagnosed during 2000–2003. Environmental Research 100:2, 232-241
    CrossRef

  79. 79

    Ulla M. Forssén, Stefan Lönn, Anders Ahlbom, David A. Savitz, Maria Feychting. (2006) Occupational magnetic field exposure and the risk of acoustic neuroma. American Journal of Industrial Medicine 49:2, 112-118
    CrossRef

  80. 80

    Joshua E. Muscat, Michelle Hinsvark, Mark Malkin. (2006) Mobile Telephones and Rates of Brain Cancer. Neuroepidemiology 27:1, 55-56
    CrossRef

  81. 81

    Elizabeth B. Claus, Melissa L. Bondy, Joellen M. Schildkraut, Joseph L. Wiemels, Margaret Wrensch, Peter M. Black. (2005) Epidemiology of Intracranial Meningioma. Neurosurgery1088-1095
    CrossRef

  82. 82

    M J Schoemaker, A J Swerdlow, A Ahlbom, A Auvinen, K G Blaasaas, E Cardis, H Collatz Christensen, M Feychting, S J Hepworth, C Johansen, L Klæboe, S Lönn, P A McKinney, K Muir, J Raitanen, T Salminen, J Thomsen, T Tynes. (2005) Mobile phone use and risk of acoustic neuroma: results of the Interphone case–control study in five North European countries. British Journal of Cancer 93:7, 842-848
    CrossRef

  83. 83

    Preetha Rajaraman, Brian S. Schwartz, Nathaniel Rothman, Meredith Yeager, Howard A. Fine, William R. Shapiro, Robert G. Selker, Peter M. Black, Peter D. Inskip. (2005) δ-Aminolevulinic Acid Dehydratase Polymorphism and Risk of Brain Tumors in Adults. Environmental Health Perspectives 113:9, 1209-1211
    CrossRef

  84. 84

    Elizabeth E. Hatch, Martha S. Linet, Jianying Zhang, Howard A. Fine, William R. Shapiro, Robert G. Selker, Peter M. Black, Peter D. Inskip. (2005) Reproductive and hormonal factors and risk of brain tumors in adult females. International Journal of Cancer 114:5, 797-805
    CrossRef

  85. 85

    Stefan L??nn, Anders Ahlbom, Per Hall, Maria Feychting. (2005) Mobile Phone Use and Acoustic Neuromas. Epidemiology 16:3, 417-418
    CrossRef

  86. 86

    Robert E. Tarone, Peter D. Inskip. (2005) Mobile Phone Use and Acoustic Neuromas. Epidemiology 16:3, 414
    CrossRef

  87. 87

    Anna Lahkola, Tiina Salminen, Anssi Auvinen. (2005) Selection Bias Due to Differential Participation in a Case–Control Study of Mobile Phone Use and Brain Tumors. Annals of Epidemiology 15:5, 321-325
    CrossRef

  88. 88

    Maria Feychting, Anders Ahlbom, Leeka Kheifets. (2005) EMF AND HEALTH. Annual Review of Public Health 26:1, 165-189
    CrossRef

  89. 89

    S. Lonn. (2005) Long-Term Mobile Phone Use and Brain Tumor Risk. American Journal of Epidemiology 161:6, 526-535
    CrossRef

  90. 90

    Tania Carreón, Mary Ann Butler, Avima M. Ruder, Martha A. Waters, Karen E. Davis-King, Geoffrey M. Calvert, Paul A. Schulte, Barbara Connally, Elizabeth M. Ward, Wayne T. Sanderson, Ellen F. Heineman, Jack S. Mandel, Roscoe F. Morton, Douglas J. Reding, Kenneth D. Rosenman, Glenn Talaska, . (2005) Gliomas and Farm Pesticide Exposure in Women: The Upper Midwest Health Study. Environmental Health Perspectives 113:5, 546-551
    CrossRef

  91. 91

    J.C. Lin. (2005) The risk of acoustic neuromas from using cell phones. IEEE Antennas and Propagation Magazine 47:1, 183-185
    CrossRef

  92. 92

    Hiroko Ohgaki, Paul Kleihues. (2005) Epidemiology and etiology of gliomas. Acta Neuropathologica 109:1, 93-108
    CrossRef

  93. 93

    Lennart Hardell, Michael Carlberg, Kjell Hansson Mild. (2005) Case-Control Study on Cellular and Cordless Telephones and the Risk for Acoustic Neuroma or Meningioma in Patients Diagnosed 2000–2003. Neuroepidemiology 25:3, 120-128
    CrossRef

  94. 94

    Tomoyuki Shirai, Mayumi Kawabe, Toshio Ichihara, Osamu Fujiwara, Masao Taki, So-ichi Watanabe, Kanako Wake, Yukio Yamanaka, Katsumi Imaida, Makoto Asamoto, Seiko Tamano. (2005) Chronic exposure to a 1.439 GHz electromagnetic field used for cellular phones does not promote N-ethylnitrosourea induced central nervous system tumors in F344 rats. Bioelectromagnetics 26:1, 59-68
    CrossRef

  95. 95

    Brigitte Schlehofer, Iris Hettinger, Philip Ryan, Maria Blettner, Susan Preston-Martin, Julian Little, Annie Arslan, Anders Ahlbom, Graham G. Giles, Geoffrey R. Howe, Francoise Mngoz, Ylva Rodvall, Won N. Choi, Jrgen Wahrendorf. (2005) Occupational risk factors for low grade and high grade glioma: Results from an international case control study of adult brain tumours. International Journal of Cancer 113:1, 116-125
    CrossRef

  96. 96

    Avima M. Ruder, Martha A. Waters, Mary Ann Butler, Tania Carreón, Geoffrey M. Calvert, Karen E. Davis-king, Paul A. Schulte, Wayne T. Sanderson, Elizabeth M. Ward, L. Barbara Connally, Ellen F. Heineman, Jack S. Mandel, Roscoe F. Morton, Douglas J. Reding, Kenneth D. Rosenman, Glenn Talaska. (2004) Gliomas and Farm Pesticide Exposure in Men: The Upper Midwest Health Study. Archives of Environmental Health: An International Journal 59:12, 650-657
    CrossRef

  97. 97

    Stefan Lönn, Anders Ahlbom, Per Hall, Maria Feychting. (2004) Mobile Phone Use and the Risk of Acoustic Neuroma. Epidemiology 15:6, 653-659
    CrossRef

  98. 98

    David A. Savitz. (2004) Mixed Signals on Cell Phones and Cancer. Epidemiology 15:6, 651-652
    CrossRef

  99. 99

    Eva Bhler, Joachim Schz. (2004) Cellular telephone use among primary school children in Germany. European Journal of Epidemiology 19:11, 1043-1050
    CrossRef

  100. 100

    , Anders Ahlbom, Adele Green, Leeka Kheifets, David Savitz, Anthony Swerdlow. (2004) Epidemiology of Health Effects of Radiofrequency Exposure. Environmental Health Perspectives 112:17, 1741-1754
    CrossRef

  101. 101

    Michael Kundi, Kjell Hansson Mild, Lennart Hardell, Mats-Olof Mattsson. (2004) MOBILE TELEPHONES AND CANCER—A REVIEW OF EPIDEMIOLOGICAL EVIDENCE. Journal of Toxicology and Environmental Health, Part B 7:5, 351-384
    CrossRef

  102. 102

    Y. Touitou. (2004) Évaluation des effets des champs électromagnétiques sur la santé chez l’homme. Annales Pharmaceutiques Françaises 62:4, 219-232
    CrossRef

  103. 103

    Preetha Rajaraman, Anneclaire J. De Roos, Patricia A. Stewart, Martha S. Linet, Howard A. Fine, William R. Shapiro, Robert G. Selker, Peter M. Black, Peter D. Inskip. (2004) Occupation and risk of meningioma and acoustic neuroma in the United States. American Journal of Industrial Medicine 45:5, 395-407
    CrossRef

  104. 104

    Klaus Mann, Joachim Röschke. (2004) Sleep under exposure to high-frequency electromagnetic fields. Sleep Medicine Reviews 8:2, 95-107
    CrossRef

  105. 105

    Kari Tahvanainen, Juanita Nio, Pirjo Halonen, Tom Kuusela, Tomi Laitinen, Esko Lnsimies, Juha Hartikainen, Maila Hietanen, Harri Lindholm. (2004) Cellular phone use does not acutely affect blood pressure or heart rate of humans. Bioelectromagnetics 25:2, 73-83
    CrossRef

  106. 106

    Stefan Lnn, Lars Klaeboe, Per Hall, Tiit Mathiesen, Anssi Auvinen, Helle C. Christensen, Christoffer Johansen, Tiina Salminen, Tore Tynes, Maria Feychting. (2004) Incidence trends of adult primary intracerebral tumors in four Nordic countries. International Journal of Cancer 108:3, 450-455
    CrossRef

  107. 107

    Peter H Wessels, Wim EJ Weber, Guy Raven, Frans CS Ramaekers, Anton HN Hopman, Albert Twijnstra. (2003) Supratentorial grade II astrocytoma: biological features and clinical course. The Lancet Neurology 2:7, 395-403
    CrossRef

  108. 108

    Jason Heth, Ossama Al-Mefty. (2003) Overview of Meningioma Biology and Science. Techniques in Neurosurgery 9:2, 56-63
    CrossRef

  109. 109

    D. R. Cox. (2003) Communication of risk: health hazards from mobile phones. Journal of the Royal Statistical Society: Series A (Statistics in Society) 166:2, 241-246
    CrossRef

  110. 110

    B. Hocking. (2003) Update on mobile phones and health. Internal Medicine Journal 33:5-6, 235-236
    CrossRef

  111. 111

    Hillary G. Warren, Angela A. Prevatt, Kathleen A. Daly, Patrick J. Antonelli. (2003) Cellular Telephone Use and Risk of Intratemporal Facial Nerve Tumor. The Laryngoscope 113:4, 663-667
    CrossRef

  112. 112

    C La Vecchia, S Franceschi, F Levi. (2003) Epidemiological research on cancer with a focus on Europe. European Journal of Cancer Prevention 12:1, 5-14
    CrossRef

  113. 113

    J. Mark Elwood. (2003) Epidemiological studies of radio frequency exposures and human cancer. Bioelectromagnetics 24:S6, S63-S73
    CrossRef

  114. 114

    K.-A. Hossmann, D.M. Hermann. (2003) Effects of electromagnetic radiation of mobile phones on the central nervous system. Bioelectromagnetics 24:1, 49-62
    CrossRef

  115. 115

    Louis N. Heynick, Sheila A. Johnston, Patrick A. Mason. (2003) Radio frequency electromagnetic fields: Cancer, mutagenesis, and genotoxicity. Bioelectromagnetics 24:S6, S74-S100
    CrossRef

  116. 116

    Susan Preston-Martin. 2003. Central Nervous System Tumors, Epidemiology. , 557-566.
    CrossRef

  117. 117

    G.B. Gajda, J.P. McNamee, A. Thansandote, S. Boonpanyarak, E. Lemay, P.V. Bellier. (2002) Cylindrical waveguide applicator for in vitro exposure of cell culture samples to 1.9-GHz radiofrequency fields. Bioelectromagnetics 23:8, 592-598
    CrossRef

  118. 118

    M. Wrensch, Y. Minn, T. Chew, M. Bondy, M. S. Berger. (2002) Epidemiology of primary brain tumors: Current concepts and review of theliterature. Neuro-Oncology 4:4, 278-299
    CrossRef

  119. 119

    RON SWENSEN, WOLFF KIRSCH. (2002) Brain Neoplasms in Women: A Review. Clinical Obstetrics and Gynecology 45:3, 904-927
    CrossRef

  120. 120

    L Hardell, A Hallquist, K Hansson Mild, M Carlberg, A Påhlson, A Lilja. (2002) Cellular and cordless telephones and the risk for brain tumours. European Journal of Cancer Prevention 11:4, 377-386
    CrossRef

  121. 121

    Elihu D. Richter, Tamar Berman, Or Levy. (2002) Brain Cancer with Induction Periods of Less Than 10 Years in Young Military Radar Workers. Archives of Environmental Health: An International Journal 57:4, 270-272
    CrossRef

  122. 122

    Adam Burgess. (2002) Comparing national responses to perceived health risks from mobile phone masts. Health, Risk & Society 4:2, 175-188
    CrossRef

  123. 123

    Alina V. Brenner, Martha S. Linet, Howard A. Fine, William R. Shapiro, Robert G. Selker, Peter M. Black, Peter D. Inskip. (2002) History of allergies and autoimmune diseases and risk of brain tumors in adults. International Journal of Cancer 99:2, 252-259
    CrossRef

  124. 124

    Anssi Auvinen, Maila Hietanen, Ritva Luukkonen, Riitta-Sisko Koskela. (2002) Brain Tumors and Salivary Gland Cancers Among Cellular Telephone Users. Epidemiology 13:3, 356-359
    CrossRef

  125. 125

    C Johansen, J D Boice, J K McLaughlin, H C Christensen, J H Olsen. (2002) Mobile phones and malignant melanoma of the eye. British Journal of Cancer 86:3, 348-349
    CrossRef

  126. 126

    L Hardell, K Hansson Mild, A Påhlson, A Hallquist. (2001) Ionizing radiation, cellular telephones and the risk for brain tumours. European Journal of Cancer Prevention 10:6, 523-529
    CrossRef

  127. 127

    Pamela New. (2001) Radiation injury to the nervous system. Current Opinion in Neurology 14:6, 725-734
    CrossRef

  128. 128

    Alba A Brandes, Umberto Basso, Lara M Pasetto. (2001) Changing boundaries in the treatment of malignant gliomas. Expert Review of Anticancer Therapy 1:3, 357-370
    CrossRef

  129. 129

    Faith G Davis, Bridget J McCarthy. (2001) Current epidemiological trends and surveillance issues in brain tumors. Expert Review of Anticancer Therapy 1:3, 395-401
    CrossRef

  130. 130

    C. Johansen. (2001) Response: Cellular Telephones and Cancer--a Nationwide Cohort Study in Denmark. Journal of the National Cancer Institute 93:11, 878a-879
    CrossRef

  131. 131

    J.C. Lin. (2001) Risk of human exposure to cellular mobile communication radiation. IEEE Microwave Magazine 2:2, 36-40
    CrossRef

  132. 132

    (2001) Brain Tumors. New England Journal of Medicine 344:19, 1478-1479
    Full Text

  133. 133

    James G. Gurney, Nina Kadan-Lottick. (2001) Brain and other central nervous system tumors: rates, trends, and epidemiology. Current Opinion in Oncology 13:3, 160-166
    CrossRef

  134. 134

    (2001) Cellular Telephones and Brain Tumors. New England Journal of Medicine 344:17, 1331-1332
    Full Text

  135. 135

    J.C. Lin. (2001) The precautionary principle: a rose by another name [cellular radio health effects]. IEEE Antennas and Propagation Magazine 43:2, 129-131
    CrossRef

  136. 136

    Mark A. Bullimore. (2001) Are Cell Phones Bad for Your Health?. Optometry and Vision Science 78:3, 129
    CrossRef

  137. 137

    R. L. Park. (2001) Cellular Telephones and Cancer: How Should Science Respond?. JNCI Journal of the National Cancer Institute 93:3, 166-167
    CrossRef

  138. 138

    C. Johansen, J. D. Boice, J. K. McLaughlin, J. H. Olsen. (2001) Cellular Telephones and Cancer--a Nationwide Cohort Study in Denmark. JNCI Journal of the National Cancer Institute 93:3, 203-207
    CrossRef

  139. 139

    Gellin, Bruce G., Schaffner, William, . (2001) The Risk of Vaccination — The Importance of “Negative” Studies. New England Journal of Medicine 344:5, 372-373
    Full Text

  140. 140

    DeAngelis, Lisa M., . (2001) Brain Tumors. New England Journal of Medicine 344:2, 114-123
    Full Text

  141. 141

    Trichopoulos, Dimitrios, , Adami, Hans-Olov, . (2001) Cellular Telephones and Brain Tumors. New England Journal of Medicine 344:2, 133-134
    Full Text